pharmaceutical sales and marketing News
Most Popular pharmaceutical sales and marketing Story
Bloomberg: J&J's Risperdal settlement to top $1B
Johnson & Johnson's ($JNJ) long-awaited Risperdal marketing settlement is set to top $1 billion, Bloomberg's sources say. If so, that would put it in third place among off-label marketing probes, Read more...
Latest Headlines
- January 6, 2012
- November 10, 2011
- November 3, 2011
- October 21, 2011
- October 13, 2011
- July 7, 2011
- May 27, 2011
- January 10, 2011
- January 4, 2011
- December 27, 2010
- December 22, 2010
- December 15, 2010
- December 9, 2010
- December 1, 2010
- July 28, 2010
- July 14, 2010
- May 19, 2010
- March 23, 2010
- March 12, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
